Major funding to develop slow-releasing antimicrobial agent for dentistry and medicine

A University of Bristol spin-out company working to advance the treatment and prevention of bacterial infection by developing a solution to improve the efficacy of chlorhexidine-based products has received major investment to progress the technology.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Business and Enterprise, Grants and Awards, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, School of Oral and Dental Sciences; Press Release Source Type: news